Related Experiment Videos
Retention in methadone maintenance treatment programs, Connecticut and Massachusetts, 1990-1993
R J MacGowan1, N M Swanson, R M Brackbill
1Centers for Disease Control and Prevention, National Center HIV/STD/TB Prevention, Atlanta, Georgia 30333, USA.
Journal of Psychoactive Drugs
|July 1, 1996
Summary
Older age, enrollment in primary care models, and not injecting drugs at three months are key to retaining patients in methadone maintenance treatment programs (MMTPs). These factors improve patient outcomes and reduce HIV transmission risks.
Area of Science:
- Addiction Medicine
- Public Health
- Health Services Research
Background:
- Methadone maintenance treatment programs (MMTPs) are crucial for managing opioid use disorder.
- High retention rates in MMTPs are linked to reduced drug use and HIV transmission among injection drug users (IDUs).
- Understanding factors influencing long-term treatment engagement is vital for program effectiveness.
Purpose of the Study:
- To identify demographic and clinical factors associated with sustained retention in MMTPs.
- To compare retention rates across different MMTP models (12-Step, case management, primary care).
- To inform strategies for improving patient adherence and treatment outcomes.
Main Methods:
- Analysis of data from 674 participants across MMTPs in Massachusetts and Connecticut.
- Utilized ethnographic methods and logistic regression for data analysis.
- Examined retention at six and 12 months post-enrollment.
Main Results:
- Overall retention rates were 69% at six months and 48% at 12 months.
- Factors independently associated with retention included increased client age, cessation of injecting drug use by three months, and enrollment in primary care models.
- Younger IDUs and those still injecting at three months showed lower retention rates.
Conclusions:
- Older age, not injecting drugs by three months, and primary care models are positively associated with MMTP retention.
- Targeted interventions and alternative treatment regimens may be necessary for younger IDUs and those still injecting.
- MMTP directors should evaluate program structures to enhance client retention and reduce associated health risks.